Captrust Financial Advisors Haemonetics Corp Transaction History

Captrust Financial Advisors

  • $38.8 Billion
  • Q1 2025

A detailed history of Captrust Financial Advisors transactions in Haemonetics Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 4,361 shares of HAE stock, worth $312,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,361
Previous 4,872 10.49%
Holding current value
$312,465
Previous $380,000 27.11%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$59.34 - $80.05 $30,322 - $40,905
-511 Reduced 10.49%
4,361 $277,000
Q4 2024

Feb 14, 2025
BUY
$71.16 - $93.38 $44,403 - $58,269
624 Added 14.69%
4,872 $380,000
Q3 2024

Nov 14, 2024
BUY
$72.45 - $91.58 $71,145 - $89,931
982 Added 30.07%
4,248 $341,000
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $5,036 - $6,036
62 Added 1.94%
3,266 $270,000
Q1 2024

May 15, 2024
SELL
$71.24 - $85.35 $238,867 - $286,178
-3,353 Reduced 51.14%
3,204 $273,000
Q4 2023

Feb 14, 2024
SELL
$80.59 - $92.61 $343,716 - $394,981
-4,265 Reduced 39.41%
6,557 $560,000
Q3 2023

Nov 14, 2023
BUY
$82.56 - $93.49 $153,974 - $174,358
1,865 Added 20.82%
10,822 $969,000
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $724,083 - $801,203
8,957 New
8,957 $762,000
Q2 2022

Aug 23, 2022
SELL
$49.27 - $66.08 $5,370 - $7,202
-109 Reduced 4.62%
2,250 $147,000
Q2 2022

Aug 16, 2022
BUY
$49.27 - $66.08 $1,182 - $1,585
24 Added 1.03%
2,359 $154,000
Q1 2022

May 16, 2022
BUY
$43.77 - $63.22 $25,605 - $36,983
585 Added 33.43%
2,335 $148,000
Q4 2021

Feb 14, 2022
SELL
$49.55 - $74.59 $20,067 - $30,208
-405 Reduced 18.79%
1,750 $93,000
Q3 2021

Nov 16, 2021
BUY
$57.6 - $70.59 $6,048 - $7,411
105 Added 5.12%
2,155 $152,000
Q2 2021

Aug 16, 2021
BUY
$51.81 - $118.56 $2,072 - $4,742
40 Added 1.99%
2,050 $137,000
Q1 2021

May 17, 2021
BUY
$111.01 - $139.48 $208,143 - $261,524
1,875 Added 1388.89%
2,010 $223,000
Q3 2020

Nov 17, 2020
BUY
$75.65 - $93.58 $8,321 - $10,293
110 Added 440.0%
135 $12,000
Q2 2020

Aug 14, 2020
BUY
$84.96 - $118.91 $2,124 - $2,972
25 New
25 $2,000
Q4 2019

Feb 14, 2020
SELL
$114.37 - $129.46 $2,859 - $3,236
-25 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$81.74 - $120.34 $2,043 - $3,008
25 New
25 $3,000

Others Institutions Holding HAE

# of Institutions
351
Shares Held
53.3M
Call Options Held
417K
Put Options Held
314K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.68B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email